Clinical trial
Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery…
NCT00499083 · University of Nebraska, Other · Completed
Key facts
| NCT number | NCT00499083 |
|---|---|
| Title | Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women) |
| Official title | Neoadjuvant Intratumoral Injection of Dendritic Cells in Breast Cancer Translation of Biotechnology Into the Clinic |
| Lead sponsor | University of Nebraska, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological, Drug, Genetic, Other, Procedure, Radiation |
| Interventions | therapeutic autologous dendritic cells, aromatase inhibition therapy, cyclophosphamide, doxorubicin hydrochloride, paclitaxel, tamoxifen citrate, gene expression analysis, protein expression analysis, reverse transcriptase-polymerase chain reaction, immunoenzyme technique and 7 more |
| Enrollment | 17 |
| Start date | May 1, 2006 |
| Primary completion | Jul 1, 2009 |
| Completion | Jan 28, 2010 |
| First posted | Jul 11, 2007 |
| Last update posted | Sep 29, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: